FDA Nominee Overton Defends Vaccines, Dodges Abortion Pill Questions in Senate Hearing

Key points

• Overton stated that the MMR vaccine is 'safe and effective' and the best tool against the current measles outbreak, contradicting President Trump's recent assertion that the vaccine is 'lethal.'
• She affirmed that all vaccines on the U.S. market meet FDA safety standards but refused to directly label the President's comments as wrong, stating her role is to describe current scientific knowledge.
• Regarding mifepristone, Overton confirmed the drug is safe and effective as labeled, citing an ongoing safety review, but avoided committing to specific restrictions or expansions of access.
• Sen. Bernie Sanders pressed Overton on universal healthcare, which she declined to endorse, instead citing the FDA's statutory responsibilities and recent drops in prescription drug prices.
• The confirmation process remains stalled, with key Republican senators like Bill Cassidy and Lisa Murkowski expressing concerns about political pressure on regulatory decisions.

Background

Overton’s nomination follows the resignation of FDA commissioner Marty Makary earlier in 2026. Previous coverage indicated that her confirmation was already fraught with opposition from both sides of the aisle, with critics questioning her regulatory experience and her alignment with the White House’s anti-vaccine rhetoric. The current hearing occurs amidst a broader pattern of Trump administration nominees distancing themselves from the President’s views on vaccine safety to secure Senate support.

How outlets are covering it

Axios highlights the tension between Overton’s testimony and her previous public statements, noting she previously called mifepristone 'dangerous' but now emphasizes its safety under current FDA standards. Politico frames the hearing as part of a broader trend where Trump’s health nominees, including Overton and surgeon general nominee Nicole Saphier, are breaking with the President and Health Secretary Robert F. Kennedy Jr. on vaccine safety to ensure confirmation. Fox News focuses on the clash between Overton and Sen. Bernie Sanders, noting her refusal to endorse universal healthcare as a human right and her defense of the administration’s drug pricing policies. The Santa Fe New Mexican provides local context on Overton’s background but offers limited new details on the hearing’s substance.

Why it matters

The outcome of Overton’s confirmation will determine the leadership of the FDA during a period of significant regulatory uncertainty. Her stance on vaccines and abortion pills could influence public health policy and access to critical medications, while the lack of a confirmed commissioner may delay crucial decisions on drug approvals and safety reviews.

What to watch

Senators will likely vote on Overton’s nomination after the midterm elections, as the current congressional calendar offers little time for a final decision. Ongoing Department of Health and Human Services studies on vaccine and mifepristone safety may provide new evidence to support or challenge current regulatory policies.